IQWiG evaluates smoking cessation drugs for severe tobacco dependence treatment

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

By law, smokers with severe tobacco dependence are entitled to receive one-off drug therapy for smoking cessation as part of evidence-based programmes reimbursed by the German statutory health insurance (SHI).